内窥镜狭窄管理市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

在预测期内，内窥镜狭窄管理市场预计将以近 6.0% 的复合年增长率增长。

市场增长的主要驱动力是全球胃肠道 (GI) 和食道疾病患病率上升，例如炎症性肠病、胃食管反流病 (GERD)、心血管出血、胃肠道出血和肥胖以及糖尿病等其他慢性疾病人口老龄化 例如，根据国际胃肠道疾病基金会 2019 年发布的报告，GERD 影响了大约三分之一的总人口，需要有效治疗，并正在推动全球市场增长。

主要市场趋势

在内窥镜狭窄管理市场，支架有望占据最大市场份额

• 支架预计将在整个预测期内主导市场，因为技术进步提高了安全性和便利性，这些设备的采用率显着增加。 由于其自膨胀和可生物降解的特性，它也直接归因于医疗保健专业人员越来越喜欢它，这推动了全球内窥镜狭窄管理市场的收入增长。
• 在最终用户方面，医院占据了最高的市场份额，这可以归因于以下因素：与医院相关的疾病（例如埋藏的阴茎、肠易激综合症和胃食管反流病）的数量不断增加；对微创手术的偏好；飙升的偏好，有利的报销政策以及在这些环境中增强的患者护理预计将推动对该细分市场的需求，并在预测期内推动全球内窥镜狭窄管理。

北美在市场上占主导地位，预计在预测期内也会如此。

预计在整个预测期内，北美将主导整个内窥镜狭窄管理市场。 这种优势是由于糖尿病、肥胖症和其他需要有效管理这些狭窄的胃肠道疾病等慢性病的负担不断增加。 此外，一些因素，如完善的直接报销政策和先进医疗基础设施的可用性，可能有利于该地区的市场，在预测期内为其突出的全球市场收入份额做出贡献。是的。

竞争格局

内窥镜狭窄管理市场竞争适中，由几家大型企业组成。 一些目前占据市场主导地位的主要参与者正在与其他公司进行收购以巩固其在全球的市场地位，而另一些则有助于快速准确地布局。我们正在推出具有先进技术的新产品 例如，2018 年 9 月，Zavation Medical Products 通过收购收购了 Pan Medical U.S. Corp，后者提供了一套完整的微创系统，有望对整体市场增长产生积极影响。 目前主导市场的公司包括 Boston Scientific Corporation、CONMED Corporation、Hobbs Medical Inc、Cook Medical Inc 和 Merit Medical Systems。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素
  • 老龄化人口的增加和胃肠道疾病患病率的增加
  • 推出配备先进技术的新产品并支持微创手术
• 市场製约因素
  • 昂贵的胃肠道内窥镜手术和麻烦的还款方式
  • 缺乏接受过内窥镜狭窄手术培训的熟练医疗保健专业人员
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 类型
  • 球囊扩张器
  • 支架
  • 探条扩张器
• 申请
  • 食道
  • 胆道
  • 其他
• 最终用户
  • 医院
  • 门诊手术中心
  • 其他
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Boston Scientific Corporation
  • Olympus Corporation
  • Becton, Dickinson and Company
  • Cook Group
  • CONMED Corporation
  • STERIS plc
  • Medi-Globe Corporation
  • Hobbs Medical Inc
  • PanMed US
  • Merit Medical Systems

第7章 市场机会今后动向

The endoscopic stricture management market studied was anticipated to grow with a CAGR of nearly 6.0%, during the forecast period. The major factors attributing to the growth of the market are rise in the global prevalence of gastrointestinal (GI) and esophageal disorders such as inflammatory bowel disease, gastroesophageal reflux disease (GERD), cardiac vessel bleedings, and gastrointestinal hemorrhages and other chronic diseases like obesity and diabetes with increasing geriatric population. For instance, according to the International Foundation for Gastrointestinal Disorders Report published in 2019, GERD affects about one-third of the total population necessitating effective treatment driving the growth of the global market.

Key Market Trends

Stents are Expected to Hold the Largest Market Share in the Endoscopic Stricture Management Market

• Stents are expected to dominate the market throughout the forecast period owing to the huge rise in the adoption of these devices due to their enhanced safety with technological advancements and increased convenience. Also, due to the rise in preference by the healthcare providers due to their self-expandable and bio-degradable nature which directly fuels the growth of global endoscopic stricture management market revenue.
• Based on the end-user, hospitals account for the highest market share which can be attributed to factors such as increased volume of hospital-associated diseases such as buried penis, IBS, GERD, etc., resultant rising demand for hospitals stays, steep upsurge in preference for minimally invasive surgical procedures, and favorable reimbursement policies along with enhanced patient care in these settings are expected to drive the demand for the segment and propel the global endoscopic stricture management during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall endoscopic stricture management market throughout the forecast period. The dominance is due to the rise in chronic diseases such as diabetes and obesity, other GI disorders necessitating effective management of these strictures to decrease the rising burden. Also, several factors such as well-established direct reimbursement policies and the availability of advanced healthcare infrastructure may favor the market in this region contributing to its outstanding global market revenue share during the forecast period.

Competitive Landscape

The endoscopic stricture management market is moderately competitive and consists of several major players. Few of the major players currently dominating the market are making acquisitions with the other companies to consolidate their market positions across the globe and while others are launching new products with advanced technologies to facilitate fast and accurate placement. For instance, in September 2018, Zavation Medical Products acquired Pan Medical U.S. Corp through the acquisition, the company offers a full suite of minimally invasive systems which is expected to have a positive impact on the overall market growth. Some of the companies which are currently dominating the market are Boston Scientific Corporation, CONMED Corporation, Hobbs Medical Inc, Cook Medical Inc, and Merit Medical Systems

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Geriatric Popuation and Rise in Prevalence of GI Disorders
  • 4.2.2 New Product Launches with Advanced Technologies and Prefernce for Minimal Invasive Procedures
• 4.3 Market Restraints
  • 4.3.1 Highly Expensive GI Endoscopic Procedures and Troublesome Repayment Approaches
  • 4.3.2 Lack of Trained and Skilled Healthcare Professionals in Endoscopic Stricture Technology
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 Type
  • 5.1.1 Balloon Dilators
  • 5.1.2 Stents
  • 5.1.3 Bougie Dilators
• 5.2 Application
  • 5.2.1 Esophageal
  • 5.2.2 Biliary
  • 5.2.3 Others
• 5.3 End-User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Others
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Boston Scientific Corporation
  • 6.1.2 Olympus Corporation
  • 6.1.3 Becton, Dickinson and Company
  • 6.1.4 Cook Group
  • 6.1.5 CONMED Corporation
  • 6.1.6 STERIS plc
  • 6.1.7 Medi-Globe Corporation
  • 6.1.8 Hobbs Medical Inc
  • 6.1.9 PanMed US
  • 6.1.10 Merit Medical Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS